• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体在肾小球健康和疾病中的作用。

Lysosome function in glomerular health and disease.

机构信息

Institute for Cellular and Integrative Physiology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

出版信息

Cell Tissue Res. 2021 Aug;385(2):371-392. doi: 10.1007/s00441-020-03375-7. Epub 2021 Jan 12.

DOI:10.1007/s00441-020-03375-7
PMID:33433692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8523507/
Abstract

The lysosome represents an important regulatory platform within numerous vesicle trafficking pathways including the endocytic, phagocytic, and autophagic pathways. Its ability to fuse with endosomes, phagosomes, and autophagosomes enables the lysosome to break down a wide range of both endogenous and exogenous cargo, including macromolecules, certain pathogens, and old or damaged organelles. Due to its center position in an intricate network of trafficking events, the lysosome has emerged as a central signaling node for sensing and orchestrating the cells metabolism and immune response, for inter-organelle and inter-cellular signaling and in membrane repair. This review highlights the current knowledge of general lysosome function and discusses these findings in their implication for renal glomerular cell types in health and disease including the involvement of glomerular cells in lysosomal storage diseases and the role of lysosomes in nongenetic glomerular injuries.

摘要

溶酶体是众多囊泡运输途径(包括内吞作用、吞噬作用和自噬途径)中的一个重要调节平台。它能够与内体、吞噬体和自噬体融合,使溶酶体能够分解广泛的内源性和外源性货物,包括大分子、某些病原体以及衰老或受损的细胞器。由于它在复杂的运输事件网络中处于中心位置,溶酶体已成为感应和协调细胞代谢和免疫反应的中央信号节点,用于细胞器间和细胞间信号传递以及膜修复。本综述强调了溶酶体一般功能的现有知识,并讨论了这些发现对健康和疾病状态下肾小球细胞类型的影响,包括肾小球细胞在溶酶体贮积病中的作用以及溶酶体在非遗传肾小球损伤中的作用。

相似文献

1
Lysosome function in glomerular health and disease.溶酶体在肾小球健康和疾病中的作用。
Cell Tissue Res. 2021 Aug;385(2):371-392. doi: 10.1007/s00441-020-03375-7. Epub 2021 Jan 12.
2
Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.足细胞溶酶体功能障碍在慢性肾小球疾病中的作用。
Int J Mol Sci. 2020 Feb 25;21(5):1559. doi: 10.3390/ijms21051559.
3
Acquired glomerular lesions in patients with Down syndrome.唐氏综合征患者获得性肾小球病变。
Hum Pathol. 2012 Jan;43(1):81-8. doi: 10.1016/j.humpath.2011.04.009. Epub 2011 Jul 5.
4
Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes.自噬成熟与 CD38 介导的溶酶体功能调节相关在小鼠肾小球足细胞中。
J Cell Mol Med. 2013 Dec;17(12):1598-607. doi: 10.1111/jcmm.12173. Epub 2013 Nov 17.
5
HIV-associated nephropathy: experimental models.人类免疫缺陷病毒相关性肾病:实验模型
Contrib Nephrol. 2011;169:270-285. doi: 10.1159/000320212. Epub 2011 Jan 20.
6
Peripolar cells and other granulated epithelial cells in renal biopsies.肾活检中的极周细胞和其他颗粒状上皮细胞。
APMIS. 1992 Aug;100(8):701-8. doi: 10.1111/j.1699-0463.1992.tb03987.x.
7
CD44 is required for the pathogenesis of experimental crescentic glomerulonephritis and collapsing focal segmental glomerulosclerosis.CD44 在实验性新月体性肾小球肾炎和局灶性节段性肾小球硬化症的发病机制中起关键作用。
Kidney Int. 2018 Mar;93(3):626-642. doi: 10.1016/j.kint.2017.09.020. Epub 2017 Dec 21.
8
Diffuse glomerulosclerosis--a dysfunction of the mesangium? A morphometric study of the rat's kidney.弥漫性肾小球硬化——系膜的功能障碍?大鼠肾脏的形态计量学研究。
Virchows Arch B Cell Pathol Incl Mol Pathol. 1979;31(3):205-10. doi: 10.1007/BF02889937.
9
Diabetic nephropathy with anti-GBM nephritis.糖尿病肾病合并抗肾小球基底膜肾炎
Am J Kidney Dis. 1998 Jan;31(1):127-30. doi: 10.1053/ajkd.1998.v31.pm9428463.
10
Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.特发性膜性肾病患者肾小球中溶酶体膜蛋白2表达增加。
Proteomics. 2015 Nov;15(21):3722-30. doi: 10.1002/pmic.201500127. Epub 2015 Sep 28.

引用本文的文献

1
Lysosome-dependent cell death: disease implications and potential therapeutic targets.溶酶体依赖性细胞死亡:疾病影响及潜在治疗靶点
Mol Biol Rep. 2025 Sep 10;52(1):881. doi: 10.1007/s11033-025-10997-z.
2
Mechanisms of NLRP3 inflammasome in chronic kidney disease and the effects of traditional Chinese medicines.NLRP3炎性小体在慢性肾脏病中的作用机制及中药的影响
Ren Fail. 2025 Dec;47(1):2538798. doi: 10.1080/0886022X.2025.2538798. Epub 2025 Aug 21.
3
The Life of a Kidney Podocyte.肾足细胞的生命历程。

本文引用的文献

1
Autophagy and Glomerular Diseases.自噬与肾小球疾病。
Adv Exp Med Biol. 2020;1207:481-486. doi: 10.1007/978-981-15-4272-5_35.
2
Distinct Modes of Balancing Glomerular Cell Proteostasis in Mucolipidosis Type II and III Prevent Proteinuria.Ⅱ型和Ⅲ型黏脂贮积症中肾小球细胞蛋白稳态平衡的不同模式可预防蛋白尿。
J Am Soc Nephrol. 2020 Aug;31(8):1796-1814. doi: 10.1681/ASN.2019090960. Epub 2020 Jul 8.
3
Podocytopathy and Nephrotic Syndrome in Mice with Podocyte-Specific Deletion of the Asah1 Gene: Role of Ceramide Accumulation in Glomeruli.
Acta Physiol (Oxf). 2025 Aug;241(8):e70081. doi: 10.1111/apha.70081.
4
The intelligent podocyte: sensing and responding to a complex microenvironment.智能足细胞:感知并响应复杂的微环境。
Nat Rev Nephrol. 2025 May 8. doi: 10.1038/s41581-025-00965-y.
5
Dynll1-PI31 Interaction Enhances Proteolysis Through the Proteasome, Representing a Novel Therapeutic Target for INF2-Related FSGS.Dynll1与PI31的相互作用通过蛋白酶体增强蛋白水解作用,是与INF2相关的局灶节段性肾小球硬化症的新型治疗靶点。
Kidney360. 2025 Jan 1;6(1):38-48. doi: 10.34067/KID.0000000659. Epub 2024 Dec 2.
6
Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?黏多糖贮积症伴多发畸形综合征:这是一种黏多糖贮积症,还是一种独立的代谢疾病?
Int J Mol Sci. 2024 Sep 4;25(17):9570. doi: 10.3390/ijms25179570.
7
Effect of Alpha-1 Antitrypsin and Irisin on Post-Exercise Inflammatory Response: A Narrative Review.α-1 抗胰蛋白酶和鸢尾素对运动后炎症反应的影响:叙事性综述。
Iran J Med Sci. 2024 Apr 1;49(4):205-218. doi: 10.30476/IJMS.2023.97480.2925. eCollection 2024 Apr.
8
The proteasome modulates endocytosis specifically in glomerular cells to promote kidney filtration.蛋白酶体特异性调节肾小球细胞内吞作用,促进肾脏过滤。
Nat Commun. 2024 Mar 1;15(1):1897. doi: 10.1038/s41467-024-46273-0.
9
Bioinformatics analysis of immune cell infiltration patterns and potential diagnostic markers in atherosclerosis.动脉粥样硬化中免疫细胞浸润模式及潜在诊断标志物的生物信息学分析。
Sci Rep. 2023 Nov 14;13(1):19821. doi: 10.1038/s41598-023-47257-8.
10
Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism.天然多酚通过调控自噬治疗糖尿病肾病的作用及机制研究
Front Endocrinol (Lausanne). 2023 Aug 10;14:1142276. doi: 10.3389/fendo.2023.1142276. eCollection 2023.
足细胞特异性敲除 Asah1 基因的小鼠足细胞病和肾病综合征:肾小球中神经酰胺积累的作用。
Am J Pathol. 2020 Jun;190(6):1211-1223. doi: 10.1016/j.ajpath.2020.02.008. Epub 2020 Mar 16.
4
Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss.法布里肾病中足细胞内神经节苷脂 GM3 的积累与足细胞进行性丢失有关。
J Am Soc Nephrol. 2020 Apr;31(4):865-875. doi: 10.1681/ASN.2019050497. Epub 2020 Mar 3.
5
A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients.一种新型的磷脂酶A2受体1相关膜性肾病小鼠模型可模拟患者足细胞损伤。
Kidney Int. 2020 May;97(5):913-919. doi: 10.1016/j.kint.2019.10.022. Epub 2019 Nov 9.
6
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes.在缺乏芳基硫酸酯酶B的小鼠中,酶替代疗法作用于骨重塑细胞,而非软骨细胞。
Hum Mol Genet. 2020 Mar 27;29(5):803-816. doi: 10.1093/hmg/ddaa006.
7
Lysosomes as dynamic regulators of cell and organismal homeostasis.溶酶体作为细胞和整体内稳态的动态调节剂。
Nat Rev Mol Cell Biol. 2020 Feb;21(2):101-118. doi: 10.1038/s41580-019-0185-4. Epub 2019 Nov 25.
8
Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease.溶酶体修复激活足细胞自噬:糖尿病肾病的一种新治疗策略。
Cell Death Dis. 2019 Oct 24;10(11):806. doi: 10.1038/s41419-019-2002-6.
9
Analysis of urinary sphingolipids using liquid chromatography-tandem mass spectrometry in diabetic nephropathy.采用液相色谱-串联质谱法分析糖尿病肾病患者的尿鞘氨醇脂质。
J Diabetes Investig. 2020 Mar;11(2):441-449. doi: 10.1111/jdi.13154. Epub 2019 Oct 21.
10
Lysosomal integral membrane protein-2 (LIMP-2/SCARB2) is involved in lysosomal cholesterol export.溶酶体整合膜蛋白-2(LIMP-2/SCARB2)参与溶酶体胆固醇外排。
Nat Commun. 2019 Aug 6;10(1):3521. doi: 10.1038/s41467-019-11425-0.